icone plus
Contact
Abonnez-vous aux actualités
Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
D03VNhmbdnEpg2gz